Hasan Yazici

Summary

Publications

  1. ncbi Behçet's syndrome: an update
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, Cerrrahpa Medical Faculty, University of Istanbul, Aksarary 34303, Istanbul, Turkey
    Curr Rheumatol Rep 5:195-9. 2003
  2. ncbi Behçet's syndrome: disease manifestations, management, and advances in treatment
    Hasan Yazici
    Department of Medicine and the Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Nat Clin Pract Rheumatol 3:148-55. 2007
  3. ncbi Diagnostic versus classification criteria - a continuum
    Hasan Yazici
    Department of Medicine, University of Istanbul, Turkey
    Bull NYU Hosp Jt Dis 67:206-8. 2009
  4. ncbi Behçet disease
    H Yazici
    Division of Rheumatology, Department of Medicine Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Curr Opin Rheumatol 13:18-22. 2001
  5. ncbi What is wrong with what is said?
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, University of Istanbul, Turkey
    Bull NYU Hosp Jt Dis 66:140-2. 2008
  6. ncbi Mortality in Behçet's syndrome
    H Yazici
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Clin Exp Rheumatol 26:S138-40. 2008
  7. ncbi The lumps and bumps of Behçet's syndrome
    H Yazici
    Division of Rheumatology, Dept of Medecine, Cerrahpasa Medical Faculty, University of Istanbul, Aksaray, Istanbul, 34303 Turkey
    Autoimmun Rev 3:S53-4. 2004
  8. doi Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial
    Vedat Hamuryudan
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Aksaray, 34365, Istanbul, Turkey
    Rheumatology (Oxford) 49:173-7. 2010
  9. doi Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients
    Emire Seyahi
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Medicine (Baltimore) 91:35-48. 2012
  10. doi Pulmonary artery involvement in Behçet׳s syndrome: Effects of anti-Tnf treatment
    Vedat Hamuryudan
    Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, Fatih, Istanbul, Turkey Electronic address
    Semin Arthritis Rheum 45:369-73. 2015

Collaborators

Detail Information

Publications83

  1. ncbi Behçet's syndrome: an update
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, Cerrrahpa Medical Faculty, University of Istanbul, Aksarary 34303, Istanbul, Turkey
    Curr Rheumatol Rep 5:195-9. 2003
    ..However, the disease burns out in many cases. Clinicians are getting better at management, and have better understanding of the old drugs, such as colchicine, and have new and potent drugs like tumor necrosis factor-alpha inhibitors...
  2. ncbi Behçet's syndrome: disease manifestations, management, and advances in treatment
    Hasan Yazici
    Department of Medicine and the Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Nat Clin Pract Rheumatol 3:148-55. 2007
    ..Although treatment of skin-mucosa manifestations, eye disease and pulmonary artery aneurysms has improved significantly in the past decades, the treatment of CNS lesions and thrombophilia are still problematic...
  3. ncbi Diagnostic versus classification criteria - a continuum
    Hasan Yazici
    Department of Medicine, University of Istanbul, Turkey
    Bull NYU Hosp Jt Dis 67:206-8. 2009
    ..The main element that makes a set of criteria diagnostic is the pretest odds. We should question our current practice of making universal disease criteria and perhaps design criteria tailored to subspecialties...
  4. ncbi Behçet disease
    H Yazici
    Division of Rheumatology, Department of Medicine Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Curr Opin Rheumatol 13:18-22. 2001
    ..The heightened inflammatory response of BD patients to simple trauma may lead to postoperative complications, but should not be regarded as a contraindication to surgery...
  5. ncbi What is wrong with what is said?
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, University of Istanbul, Turkey
    Bull NYU Hosp Jt Dis 66:140-2. 2008
    ..This interactive educational exercise is an attempt to highlight these flaws in short scenarios...
  6. ncbi Mortality in Behçet's syndrome
    H Yazici
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Clin Exp Rheumatol 26:S138-40. 2008
    ..However, this is not due to arterial involvement but due to venous disease of the lower extremities. Recently there has been a substantial decrease in mortality due to PAA thanks to prompt disease recognition and treatment...
  7. ncbi The lumps and bumps of Behçet's syndrome
    H Yazici
    Division of Rheumatology, Dept of Medecine, Cerrahpasa Medical Faculty, University of Istanbul, Aksaray, Istanbul, 34303 Turkey
    Autoimmun Rev 3:S53-4. 2004
  8. doi Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial
    Vedat Hamuryudan
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Aksaray, 34365, Istanbul, Turkey
    Rheumatology (Oxford) 49:173-7. 2010
    ..To assess the influence of being free of major organ involvement during the early years of the disease on the prognosis of men with Behçet's syndrome (BS)...
  9. doi Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients
    Emire Seyahi
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Medicine (Baltimore) 91:35-48. 2012
    ..Corticosteroids and immunosuppressive agents are the mainstays of treatment; however, refractory cases may require embolization, lobectomy, cavitectomy, and decortication...
  10. doi Pulmonary artery involvement in Behçet׳s syndrome: Effects of anti-Tnf treatment
    Vedat Hamuryudan
    Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, Fatih, Istanbul, Turkey Electronic address
    Semin Arthritis Rheum 45:369-73. 2015
    ..Anti-TNF agents are being increasingly used in patients with Behçet׳s syndrome (BS) when conventional immunosuppressives fail. However, experience with anti-TNF treatment on pulmonary artery involvement (PAI) of BS is limited...
  11. doi Colchicine in Behçet syndrome: a longterm survey of patients in a controlled trial
    Vedat Hamuryudan
    From the Behçet s Syndrome Research Center, Istanbul University, Istanbul, Turkey
    J Rheumatol 41:735-8. 2014
    ..To test the hypothesis that colchicine use during early disease decreases immunosuppressive use in Behçet syndrome (BS) in the long term...
  12. doi Behçet's syndrome
    Gulen Hatemi
    Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Cerrahpasa, Istanbul 34089, Turkey
    Rheum Dis Clin North Am 39:245-61. 2013
    ..Being a serious health problem in endemic areas, BS also attracts global attention as a model to study inflammatory diseases of unknown cause...
  13. ncbi Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study
    Melike Melikoglu
    The Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Rheumatol 32:98-105. 2005
    ..To determine the effect of the tumor necrosis factor-alpha blocker etanercept on the pathergy and monosodium urate (MSU) status and on the mucocutaneous and articular manifestations of patients with Behçet's disease (BD)...
  14. ncbi Histopathological and clinical evaluation of papulopustular lesions in Behçet's disease
    Zekayi Kutlubay
    Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Clin Exp Rheumatol 33:S101-6. 2015
    ..The aim of our current study was to further assess the clinical and histopathological features of papulopustular lesions in BD and how these features compared to those of AV...
  15. doi The papulopustular lesion/arthritis cluster of Behçet's syndrome also clusters in families
    Mehmet Karaca
    Behçet s Syndrome Research Center, Cerrahpasa Medical School, Istanbul University, Turkey
    Rheumatology (Oxford) 51:1053-60. 2012
    ..To test this hypothesis, we compared the frequency of symptom clusters between familial (group F) and non-familial (group NF) cases of BS...
  16. ncbi The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center
    Emire Kural-Seyahi
    Behçet Syndrome Research Center, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Medicine (Baltimore) 82:60-76. 2003
    ..There were no female patients with arterial aneurysms. Severely impaired vision did not always mean an eventual loss of useful vision, and those patients with a late onset of eye disease had a better visual prognosis...
  17. doi Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome
    Hasan Kilic
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Rheumatology (Oxford) 48:1388-91. 2009
    ..We investigated the efficacy and collected initial data on the safety of low-dose natural human IFN-alpha administered by the oral mucosal route in Behçet's syndrome (BS) in a placebo controlled, double blind study...
  18. ncbi Pulmonary artery aneurysms in Behçet syndrome
    Vedat Hamuryudan
    Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Am J Med 117:867-70. 2004
  19. ncbi The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey
    Emire Seyahi
    Department of Medicine, University of Istanbul, Istanbul, Turkey
    Clin Exp Rheumatol 28:S67-75. 2010
    ..We also studied HLA-B51 and MEFV mutations among a group of healthy Armenians and a non-Armenian population...
  20. ncbi Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behçet's syndrome patients with pulmonary artery involvement during follow-up
    Sinem Nihal Esatoglu
    Department of Internal Medicine, Division of Rheumatology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey
    Clin Exp Rheumatol 34:92-96. 2016
    ..However, bronchial artery enlargement (BAE) may be the source of haemoptysis in some patients...
  21. doi Venous claudication in Behçet's disease
    Serdal Ugurlu
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    J Vasc Surg 62:698-703.e1. 2015
    ..With this study, we reassessed the presence of claudication prospectively by a questionnaire and a treadmill exercise...
  22. pmc Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome: An Observational Study
    Emire Seyahi
    From the Division of Rheumatology, Department of Medicine ES, MM, HY Department of Medicine OSC Department of Radiology BT, ASD, FK Department of Cardiovascular Surgery, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul CA, HT and Department of Biostatistics, Medical Faculty, University of Trakya, Edirne, Turkey NS
    Medicine (Baltimore) 94:e1899. 2015
    ..Lower-extremity vein thrombosis associated with BS, when compared to LEVT due to other causes, had distinctive demographic and ultrasonographic characteristics, and had clinically a more severe disease course. ..
  23. doi Brief report: inadequate description and discussion of enrolled patient characteristics and potential inter-study site differences in reports of randomized controlled trials: a systematic survey in six rheumatology journals
    Sebahattin Yurdakul
    Istanbul University, Istanbul, Turkey
    Arthritis Rheumatol 66:1395-9. 2014
    ..We had the impression that many RCTs published in rheumatology journals lacked this information. This study was undertaken to systemically survey this matter in 6 leading journals...
  24. doi Management and prognosis of nonpulmonary large arterial disease in patients with Behçet disease
    Hasan Tuzun
    Department of Cardiovascular Surgery, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Vasc Surg 55:157-63. 2012
    ....
  25. doi The estimated pulmonary artery pressure can be elevated in Behçet's syndrome
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Respir Med 105:1739-47. 2011
    ....
  26. ncbi A twin study in Behçet's syndrome
    Seval Masatlioglu
    Division of Rheumatology, Haydarpaşa Numune Research and Education Hospital, Istanbul, Turkey
    Clin Exp Rheumatol 28:S62-6. 2010
    ..We sought the frequency of MZ and dizygotic (DZ) twin births in BS and compared it to a healthy population sample from the same geography. We also looked for the concordance rate among the MZ and DZ twins...
  27. doi Atherosclerosis in Behçet's Syndrome
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Semin Arthritis Rheum 38:1-12. 2008
    ..Thus, we evaluated the presence of subclinical atherosclerosis in a sizeable group of patients with BS both with major organ involvement and mucocutaneous disease along with diseased and healthy controls...
  28. doi The unique features of vasculitis in Behçet's syndrome
    Melike Melikoglu
    Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Aksaray, Istanbul, Turkey
    Clin Rev Allergy Immunol 35:40-6. 2008
    ....
  29. doi An outcome survey of 43 patients with Budd-Chiari syndrome due to Behçet's syndrome followed up at a single, dedicated center
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey 81310 Electronic address
    Semin Arthritis Rheum 44:602-9. 2015
    ..Behçet's syndrome (BS) is a well-recognized cause of Budd-Chiari syndrome (BCS); however, information about its clinical characteristics and outcome is limited...
  30. pmc Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
    Arthritis Res Ther 14:R147. 2012
    ....
  31. doi Comparative study of adhesion molecule expression in nodular lesions of Behçet syndrome and other forms of panniculitis
    Cuyan Demirkesen
    Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Am J Clin Pathol 130:28-33. 2008
    ..0208). Because many lesions of BS were related to an enhanced inflammatory response, the lower percentage of ICAM-1 expression seems counterintuitive...
  32. doi Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey
    Arthritis Rheum 58:1539-45. 2008
    ..The aim of this study was to test the hypothesis that enthesopathy is increased in this cluster, having features reminiscent of acne-associated arthritis...
  33. ncbi Headache in Behçet's syndrome
    Sabahattin Saip
    The Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Headache 45:911-9. 2005
    ..To study the frequencies and characteristics of different headache types seen in patients with Behçet's syndrome (BS) in a large cohort of patients...
  34. pmc Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014
    Gulen Hatemi
    From the Division of Rheumatology, Department of Internal Medicine, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul Division of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey Department of Internal Medicine, University Paris Diderot, Paris, France Division of Rheumatology, Koc University Faculty of Medicine, Istanbul Faculty of Health Sciences, Marmara University Department of Psychology, Istanbul University, Istanbul, Turkey Celgene Corporation, Warren, New Jersey Rutgers, Robert Wood Johnson Medical School, Department of Rheumatology, New Brunswick, New Jersey Division of Rheumatology and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA G Hatemi, MD, Associate Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, Istanbul University Cerrahpasa Faculty of Medicine Y Ozguler, MD, Fellow in Rheumatology, Division of Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine H Direskeneli, MD, Professor of Rheumatology, Division of Rheumatology, Marmara University Faculty of Medicine A Mahr, MD, PhD, Professor of Internal Medicine, Department of Internal Medicine, Germany
    J Rheumatol 42:2436-41. 2015
    ..0, and discussions during the first meeting of the BS working group held during OMERACT 12 (2014)...
  35. ncbi Fever in Behçet's syndrome
    Emire Seyahi
    University of Istanbul, Cerrahpasa Medical Faculty, Department of Rheumatology, University of Istanbul, Turkey
    Clin Exp Rheumatol 31:64-7. 2013
    ..The aim of this study was to formally investigate the presence of fever as a clinical feature in BS patients and suitable controls...
  36. doi Aortic and coronary calcifications in Takayasu arteritis
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Semin Arthritis Rheum 43:96-104. 2013
    ..We hypothesized that the degree of coronary artery calcification would point to a systemic effect of inflammation while that in the thoracic aorta more of local inflammation...
  37. doi JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome
    M Cem Ar
    Division of Hematology, Department of Internal Medicine, Istanbul Training and Research Hospital, Istanbul, Turkey
    Clin Appl Thromb Hemost 18:421-6. 2012
    ..Our data suggest that JAK2 (V617F) is not directly related to thrombosis in MPNs and in other thrombotic entities, such as BS...
  38. ncbi The management of Behçet's syndrome
    Emire Seyahi
    Division of Rheumatology, Department of Medicine Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Acta Reumatol Port 31:125-31. 2006
    ..The disease runs a more severe course among young males and the severity diminishes with age. This review describes the management of this disease, which should be individualized and varies according to site and gender...
  39. ncbi Treatment strategies for Behçet's disease
    Izzet Fresko
    Department of Rheumatology, Cerrahpasa Medical Faculty, Cerrahpasa Tip Fakultesi, Ic Hastaliklari ABD, 34300 Aksaray, Istanbul, Turkey
    Expert Opin Pharmacother 9:3211-9. 2008
    ..It is rare in the Western world but is frequent in the Middle and Far East...
  40. ncbi Fatigue is correlated with disease activity but not with the type of organ involvement in Behçet's syndrome: a comparative clinical survey
    Deram Buyuktas
    Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey and Georg August University, University Medical Center Gottingen, Department of Hematology Oncology, Gottingen, Germany
    Clin Exp Rheumatol 33:S107-12. 2015
    ..We aimed to evaluate the severity and impact of fatigue in Behçet's syndrome (BS) and to determine its association with type of organ involvement and gender...
  41. ncbi Infliximab does not suppress the tuberculin skin test (purified protein derivative)
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Department of Internal Medicine, Rheumatology Division and Haydarpasa Numune Hospital, Department of Internal Medicine, Istanbul, Turkey
    J Rheumatol 34:474-80. 2007
    ..We assessed whether infliximab, a strong inhibitor of inflammation, suppressed dermal induration, the outcome of this test. We also reassessed the booster phenomenon and the interobserver variability in tuberculin testing...
  42. ncbi Behçet syndrome
    Sebahattin Yurdakul
    Division of Rheumatology, Department of Medicin, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Curr Opin Rheumatol 16:38-42. 2004
    ..Interest in Behçet syndrome (BS), although the condition is rare in many parts of the world, is increasing as judged by the growing number of related publications and scientific meetings...
  43. ncbi Thought barriers to understanding rheumatic diseases--Halstead R. Holman revisited
    Hasan Yazici
    Department of Medicine, Division of Rheumatology, Cerrahpasa School of Medicine, University of Istanbul, Istanbul, Turkey
    Bull NYU Hosp Jt Dis 68:143-6. 2010
    ..misuse of the controlled clinical trial. The popular inductive reasoning with the propensity to prove rather than to falsify one's self might be the common denominator in many of the barriers discussed...
  44. doi Behçet's syndrome
    Sebahattin Yurdakul
    Department of Medicine, Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Best Pract Res Clin Rheumatol 22:793-809. 2008
    ....
  45. ncbi Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers
    Melike Melikoglu
    Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    J Immunol 177:6415-21. 2006
    ....
  46. pmc Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet's Syndrome: A Strobe-Compliant Observational Study From a Dedicated Multidisciplinary Center
    Ibrahim Hatemi
    From the Division of Gastroenterology, Department of Internal Medicine IH, Ye, AFC, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey and Division of Rheumatology SNE GH, HY, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Medicine (Baltimore) 95:e3348. 2016
    ..Surgery may be required for perforations or massive bleeding, and postoperative immunosuppressive treatment is necessary for preventing postoperative recurrences...
  47. ncbi Effect of colchicine on serum lipid levels
    Serdal Ugurlu
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Clin Exp Rheumatol 34:S136. 2016
    ....
  48. pmc Outcome measures used in clinical trials for Behçet syndrome: a systematic review
    Gulen Hatemi
    From the Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey Division of Rheumatology and Department of Epidemiology, University of Pennsylvania, Philadelphia, PA, USA Department of Clinical Epidemiology, VU University Medical Center, Amsterdam, the Netherlands Department of Rheumatology, Marmara University School of Medicine, Istanbul Department of Rheumatology, Istanbul Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey
    J Rheumatol 41:599-612. 2014
    ....
  49. doi Behçet's syndrome and micro-organisms
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
    Best Pract Res Clin Rheumatol 25:389-406. 2011
    ..Moreover, basic research on both viruses and bacteria suggests that micro-organisms may be playing a role, possibly through heat shock proteins and T-cell hypersensitivity...
  50. ncbi The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study
    M Cem Mat
    Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Int J Dermatol 45:554-6. 2006
    ..Although genital ulceration with or without scar formation is an important manifestation of Behçet's syndrome, formal data on the rate of genital scarring are lacking...
  51. ncbi Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study
    Vedat Hamuryudan
    Behçet s Syndrome Research Center, Cerrahpaa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Isr Med Assoc J 4:928-30. 2002
    ..Eye involvement is the main cause of morbidity in Behçet's syndrome. The efficacy of the combined use of azathioprine and interferon alfa in treating this condition has not been studied...
  52. doi An audit of Behcet's syndrome research: a 10-year survey
    Fehim Esen
    Cerrahpasa Medical Faculty and Division of Rheumatology, Istanbul University, Turkey
    J Rheumatol 38:99-103. 2011
    ..We reason that recognizing such methodological shortcomings will lead to better quality clinical and basic science articles...
  53. ncbi Behçet's disease: an MHC-I-opathy?
    Gulen Hatemi
    Department of Internal Medicine, Division of Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
    Clin Exp Rheumatol . 2016
    ....
  54. ncbi To anticoagulate or not to anticoagulate vascular thrombosis in Behçet's syndrome: an enduring question
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Clin Exp Rheumatol 34:3-4. 2016
    ....
  55. doi Behçet's syndrome: pulmonary vascular disease
    Emire Seyahi
    aEmire Seyahi, Md professor, Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey bHasan Yazici, Md professor, Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Curr Opin Rheumatol 27:18-23. 2015
    ..Most importantly, our understanding of PAI has significantly changed in recent years...
  56. doi Management of Behçet's syndrome
    Yesim Ozguler
    Istanbul University, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
    Curr Opin Rheumatol 26:285-91. 2014
    ..There is agreement that the management of Behçet's syndrome has recently improved, especially with the wider use of biologics. The aim of this review is to summarize the current management strategies in Behçet's syndrome...
  57. doi Criteria for Behçet's disease with reflections on all disease criteria
    Hasan Yazici
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey Electronic address
    J Autoimmun 48:104-7. 2014
    ..We first have to reconcile with ourselves that probabilities are very important in our practice and research. Moreover that reconciliation must also be shared with the public, which includes our patients...
  58. ncbi Beware of registries for their biases
    Hasan Yazici
    Division of Rheumatology and Department of Medicine, Istanbul University, Istanbul, Turkey
    Bull NYU Hosp Jt Dis 70:95-8. 2012
    ..This is where the mortality in a mother population lessens the mortality in the registry that stems from this mother population simply because deaths in the former cannot be represented in the latter...
  59. ncbi Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis
    Recep Tunc
    Department of Rheumatology, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Rheumatol 29:2393-6. 2002
    ..To look for target organ associations in Turkish patients with Behçet's disease (BD)...
  60. doi Takayasu disease with prominent pulmonary artery involvement: confusion with pulmonary disease leading to delayed diagnosis
    Bilgehan Karadag
    Department of Cardiology, Cerrahpasa School of Medicine, Istanbul University, 34098, Istanbul, Turkey
    Mod Rheumatol 18:507-10. 2008
    ..The frequency of such a clinical form could be underestimated given the difficulties involved in its diagnosis and because its features are similar to those of pulmonary disease...
  61. ncbi Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma
    M Cem Ar
    Department of Internal Medicine, Division of Haematology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Ann Hematol 84:609-13. 2005
    ..LV in this patient was primarily considered to be the result of progressive cryoglobulinemia, which was closely associated with MM. She was successfully managed with thalidomide and dexamethasone...
  62. pmc Intestinal permeability in Behçet's syndrome
    I Fresko
    Department of Rheumatology, Cerrahpasa Medical Faculty, Istanbul, Turkey
    Ann Rheum Dis 60:65-6. 2001
    ..To measure the intestinal permeability in patients with Behçet's syndrome (BS) and to compare the results with those obtained from healthy and diseased controls...
  63. ncbi A double-blind trial of colchicine in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Cerrahpasa Medical School, University of Istanbul, Turkey
    Arthritis Rheum 44:2686-92. 2001
    ..We reassessed the effect of colchicine in Behçet's syndrome in a study conducted among a larger group of patients for 2 years...
  64. ncbi Clinicopathologic evaluation of nodular cutaneous lesions of Behçet syndrome
    C Demirkesen
    Department of Pathology, Division of Romatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Am J Clin Pathol 116:341-6. 2001
    ..Nodular lesions of Behçet syndrome are mainly neutrophilic vascular reactions with histologic features similar to NV but significantly differing from EN associated with other systemic diseases...
  65. ncbi Behçet's disease: diagnostic and prognostic aspects of neurological involvement
    A Siva
    Department of Neurology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey
    J Neurol 248:95-103. 2001
    ..Onset with headache or a diagnosis of VST is favorable. Two major neurological diagnoses in BD are NBS and VST. These are distinct in clinical, radiological, and prognostic aspects, hence suggesting a difference in pathogenesis...
  66. pmc The pustular skin lesions in Behcet's syndrome are not sterile
    G Hatemi
    Istanbul University, Cerrahpasa Medical School, Division of Rheumatology, Istanbul, Turkey
    Ann Rheum Dis 63:1450-2. 2004
    ..The microbiology of these lesions has not been studied adequately...
  67. ncbi A cost analysis of Behcet's syndrome in Turkey
    N Sut
    Department of Biostatistics, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 46:678-82. 2007
    ..Behçet's syndrome (BS), a common chronic inflammatory disease in Turkey, results in considerable morbidity and increased mortality. We aimed to estimate its direct and indirect costs...
  68. ncbi Lactobacilli lozenges in the management of oral ulcers of Behçet's syndrome
    L Tasli
    Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Clin Exp Rheumatol 24:S83-6. 2006
    ..There is increasing evidence that lactobacilli, having anti-inflammatory activity, may be useful in some diseases, particularly in inflammatory bowel disease...
  69. doi EULAR recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 67:1656-62. 2008
    ..To develop evidence-based European League Against Rheumatism (EULAR) recommendations for the management of Behçet disease (BD) supplemented where necessary by expert opinion...
  70. doi Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 68:1528-34. 2009
    ....
  71. ncbi Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo controlled study
    F Moral
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Clin Exp Rheumatol 13:493-5. 1995
    ..05). There were also no differences in the mean numbers of acetaminophen tablets used or in the CRP and ESR levels between the two groups. We conclude that azapropazone is not effective in controlling the arthritis of Behçet's syndrome...
  72. ncbi Frequency of pathergy phenomenon and other features of Behçet's syndrome among patients with inflammatory bowel disease
    I Hatemi
    Division of Gastroenterology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Clin Exp Rheumatol 26:S91-5. 2008
    ....
  73. ncbi Behçet's syndrome is not associated with vitiligo
    M Oran
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Clin Exp Rheumatol 26:S107-9. 2008
    ..Our informal observation was that vitiligo is also uncommon among BS patients. With this controlled and masked study we formally surveyed the presence of vitiligo among BS patients and suitable controls...
  74. ncbi Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome
    I Fresko
    Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, Istanbul, Turkey
    Clin Exp Rheumatol 23:S67-70. 2005
    ..Increased as well as normal levels have been reported in Behçet's syndrome (BS). We reassessed the level of IgG and IgA ASCA antibodies in BS and in a group of diseased and healthy controls...
  75. ncbi Fibrinolytic activity and d-dimer levels in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Istanbul, Turkey
    Clin Exp Rheumatol 23:S53-8. 2005
    ..We have studied tissue-type plasminogen activator (t-PA) and its inhibitor (PAI-1), and d-dimer levels in BS patients with and without thrombosis both in the acute and chronic phases along with suitable diseased and healthy controls...
  76. ncbi A double-blind trial of depot corticosteroids in Behçet's syndrome
    C Mat
    Department of Dermatology, Bahçet s Syndrome Research Centre, Cerrahpasa Medical Faculty, Univerisity of Istanbul, Turkey
    Rheumatology (Oxford) 45:348-52. 2006
    ..We assessed the effect of depot corticosteroids primarily for genital ulcers and secondarily for the other mucocutaneous manifestations of Behçet's syndrome...
  77. pmc Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome
    R Tunc
    Department of Internal Medicine, Division of Rheumatology, Meram School of Medicine, Selcuk University, Konya, Turkey
    Ann Rheum Dis 63:1693-4. 2004
    ..To examine the association between the type of central nervous system (CNS) involvement (parenchymal disease and cerebral venous thrombosis (CVT)) and extra-cranial large vessel events, mainly venous thrombosis, in Behcet's syndrome (BS)...
  78. ncbi A reappraisal of amyloidosis in Behçet's syndrome
    M Melikoglu
    Department of Rheumatology, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 40:212-5. 2001
    ..To evaluate the clinical features and outcome of patients with Behçet's syndrome (BS) and amyloidosis and to assess the associated risk factors...
  79. ncbi Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease
    U Korman
    Department of Radiology, Cerrahpasa Medical Faculty, Istanbul University, 34300 Istanbul, Turkey
    Abdom Imaging 28:308-12. 2003
    ....
  80. ncbi Use of statistical analysis in open extension studies
    Yusuf Yazici
    J Rheumatol 33:437; author reply 437-8. 2006
  81. ncbi Behçet's syndrome: where do we stand?
    Hasan Yazici
    Am J Med 112:75-6. 2002
  82. ncbi Behçet's disease and other autoinflammatory conditions: what's in a name?
    Hasan Yazici
    Clin Exp Rheumatol 23:S1-2. 2005
  83. pmc EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
    Bernhard Hellmich
    Department of Rheumatology, University Hospital of Schleswig Holstein, Campus Lubeck, Lubeck, Germany
    Ann Rheum Dis 66:605-17. 2007
    ..To develop the European League Against Rheumatism (EULAR) recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis...